About MedGenome
The Problem MedGenome addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases. Healthcare Biotech In practice, MedGenome centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, MedGenome is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
MedGenome matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, MedGenome is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series C • Sequoia, $55M Series C in 2020, $95M valuation
Hiring Roles
This company is actively hiring.
Meet the Founders
MedGenome Team
Founder & CEO